Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Eroglu, CELALETTİN; KAYNAR, LEYLAGÜL; ORHAN, OKAN; Keklik, MUZAFFER; Sahin, Cem; YILDIZ, Orhan; Mentes, Selahattin; Kurnaz, Fatih; ASLAN, DİCLE; Sivgin, Serdar; Soyuer, Serdar; Eser, BÜLENT; Cetin, MUSTAFA; Unal, ALİ

doi:10.1097/coc.0b013e3182880b9f

Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Copy For Citation

Eroglu C., KAYNAR L., ORHAN O., Keklik M., Sahin C., YILDIZ O., ...More

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.38, no.1, pp.68-73, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 38 Issue: 1
Publication Date: 2015
Doi Number: 10.1097/coc.0b013e3182880b9f
Journal Name: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.68-73
Keywords: Hodgkin lymphoma, chemoradiotherapy, autologous stem cell transplantation, HIGH-DOSE CHEMOTHERAPY, BONE-MARROW-TRANSPLANTATION, RADIATION-THERAPY, EUROPEAN GROUP, WORKING PARTY, DISEASE, BLOOD, CHEMORADIOTHERAPY, PATTERNS, FAILURE
Erciyes University Affiliated: Yes

Abstract

Objectives: To assess the outcomes of overall survival and posttransplantation survival in patients with Hodgkin lymphoma (HL) undergoing autologous stem cell transplantation (ASCT) because of the development of relapse or resistance after chemotherapy (CT) or CT plus radiotherapy (combined modality treatment, CMT).